Roger D. Tung
Net Worth

Last updated:

What is Roger D. Tung net worth?

The estimated net worth of Dr. Roger D. Tung is at least $10,217,116 as of 6 Jan 2023. He has earned $161,356 from insider trading and has received compensation worth at least $10,055,760 in Concert Pharmaceuticals, Inc..

What is the salary of Roger D. Tung?

Dr. Roger D. Tung salary is $914,160 per year as Co-Founder, Chief Executive Officer, Pres & Executive Director in Concert Pharmaceuticals, Inc..

How old is Roger D. Tung?

Dr. Roger D. Tung is 65 years old, born in 1960.

What stocks does Roger D. Tung currently own?

As insider, Dr. Roger D. Tung owns shares in one company:

Company Title Shares Price per share Total value
Concert Pharmaceuticals, Inc. (CNCE) Co-Founder, Chief Executive Officer, Pres & Executive Director 971,018 $0 $0

What does Concert Pharmaceuticals, Inc. do?

Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has strategic collaborations with Avanir Pharmaceuticals, Inc.; Jazz Pharmaceuticals, Inc.; Cipla Technologies; and Processa Pharmaceuticals. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.

CNCE logo
CNCE
Concert Pharmaceuticals, Inc.

Roger D. Tung insider trading

Concert Pharmaceuticals, Inc.

Dr. Roger D. Tung has made 5 insider trades between 2014-2023, according to the Form 4 filled with the SEC. Most recently he sold 9,240 units of CNCE stock worth $66,898 on 6 Jan 2023.

The largest trade he's ever made was exercising 60,000 units of CNCE stock on 22 May 2014. As of 6 Jan 2023 he still owns at least 971,018 units of CNCE stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 9,240 $7.24 $66,898
Sale
Common Stock 13,480 $3.09 $41,653
Sale
Common Stock 9,240 $3.09 $28,552
Sale
Common Stock 6,700 $3.62 $24,254
Option
Stock Option (right to buy) 6,700 $3.5 $23,450
Option
Common Stock 6,700 $3.5 $23,450
Sale
Common Stock 13,480 N/A N/A
Option
Common Stock 14,601 $3.79 $55,338
Option
Stock Option (right to buy) 14,601 $3.79 $55,338
Option
Common Stock 13,166 $4.41 $58,062
Option
Employee Stock Option (Right to Buy) 13,166 $4.41 $58,062
Option
Employee Stock Option (right to buy) 14,601 $3.79 $55,338
Option
Common Stock 14,601 $3.79 $55,338
Option
Common Stock 24,886 $4.41 $109,747
Option
Employee Stock Option (right to buy) 24,886 $4.41 $109,747
Option
Common Stock 27,757 $4.58 $127,127
Option
Employee Stock Option (right to buy) 27,757 $4.58 $127,127
Option
Common Stock 7,340 $4.58 $33,617
Option
Employee Stock Option (right to buy) 7,340 $4.58 $33,617
Purchase
Common Stock 19,610 $10.55 $206,886
Option
Employee Stock Option (right to buy) 18,000 $4.58 $82,440
Option
Common Stock 18,000 $4.58 $82,440
Option
Common Stock 28,495 $1.13 $32,199
Option
Employee Stock Option (right to buy) 28,495 $1.13 $32,199
Option
Employee Stock Option (right to buy) 60,000 $1.13 $67,800
Option
Common Stock 60,000 $1.13 $67,800

Concert Pharmaceuticals key executives

Concert Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. James V. Cassella (70) Chief Devel. Officer
  • Dr. Roger D. Tung (65) Co-Founder, Chief Executive Officer, Pres & Executive Director
  • Mr. Richard H. Aldrich M.B.A., Mba (71) Co-Founder & Chairman